Co-Diagnostics Inc (CODX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,150 | -15,263 | -7,533 | -37,639 | -26,608 |
| Depreciation Amortization | 839 | 572 | 280 | 1,377 | 1,020 |
| Accounts receivable | 99 | -65 | -8 | 186 | 117 |
| Other Working Capital | -3,259 | -2,477 | -1,318 | 2,755 | 1,026 |
| Other Operating Activity | 534 | 200 | -167 | 4,166 | 3,521 |
| Operating Cash Flow | $-22,938 | $-17,033 | $-8,745 | $-29,155 | $-20,924 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -568 | -493 | -92 | -748 | -675 |
| Purchase Of Investment | -6,591 | -6,589 | -6,445 | -40,946 | -27,552 |
| Sale Of Investment | 33,762 | 31,510 | 13,894 | 58,766 | 45,032 |
| Investing Cash Flow | $26,603 | $24,428 | $7,357 | $17,071 | $16,805 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,842 | 784 | 355 | 104 | N/A |
| Financing Cash Flow | $4,842 | $784 | $355 | $104 | $N/A |
| Beginning Cash Position | 2,937 | 2,937 | 2,937 | 14,917 | 14,917 |
| End Cash Position | 11,444 | 11,115 | 1,903 | 2,937 | 10,798 |
| Net Cash Flow | $8,507 | $8,179 | $-1,034 | $-11,980 | $-4,119 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,938 | -17,033 | -8,745 | -29,155 | -20,924 |
| Capital Expenditure | -568 | -493 | -92 | -748 | -675 |
| Free Cash Flow | -23,506 | -17,526 | -8,837 | -29,903 | -21,599 |